Amag Pharmaceuticals, Inc.

MA · United States · Reporting entity ID 100000010948

Total reported 2019–2025

$10.3M

#480 of 2,960 reporting companies — 0% of all reported industry payments

$3.34M in general payments across 25,453 records, plus $6.99M in research funding across 1,311 records.

How it breaks down

General payments $3,337,635

Research funding $6,992,966

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.